Spruce Biosciences, Inc. (SPRB)

NASDAQ: SPRB · Real-Time Price · USD

43.31

+0.42 (0.98%)

At close: Nov 13, 2026, 4:00 PM EST

43.12

-0.19 (-0.44%)

After-hours: Nov 13, 2026, 7:30 PM EST

Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	87.69	48.91	38.75	96.34	24.49	42.75
Short-Term Investments	-	-	-	-	54.59	46.22
Cash & Short-Term Investments	87.69	48.91	38.75	96.34	79.08	88.97
Cash Growth	721.92%	26.20%	-59.77%	21.83%	-11.12%	-43.39%
Other Receivables	-	2.6	-	-	-	-
Receivables	-	2.6	-	-	-	-
Prepaid Expenses	2.41	0.35	3.18	3.88	3.32	2.53
Restricted Cash	-	-	-	-	0.22	-
Other Current Assets	0.2	0.25	2.28	1.97	1	0.4
Total Current Assets	90.3	52.11	44.21	102.18	83.61	91.9
Property, Plant & Equipment	0.45	0.67	0.93	1.18	1.4	1.48
Long-Term Investments	-	-	-	-	-	32.46
Other Long-Term Assets	1.2	0.24	0.07	0.58	0.64	0.65
Total Assets	91.95	53.02	45.21	103.95	85.65	126.49

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.73	0.94	1.3	3.33	1.43	2.82
Accrued Expenses	11.63	8.83	12.05	14.35	9.26	5.69
Current Portion of Long-Term Debt	4	-	1.62	1.62	1.62	-
Current Portion of Leases	0.35	0.32	0.28	0.25	0.14	0.36
Current Unearned Revenue	-	-	-	4.91	-	-
Total Current Liabilities	18.71	10.09	15.25	24.47	12.45	8.87
Long-Term Debt	3.82	-	0.12	1.72	3.29	4.88
Long-Term Leases	0.16	0.42	0.74	1.02	1.26	1.29
Other Long-Term Liabilities	2.97	-	0.28	0.24	0.16	0.07
Total Liabilities	25.65	10.51	16.39	27.44	17.16	15.12

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	-	-	-	0	0	0
Additional Paid-In Capital	408.03	331.75	279.09	273.74	218.35	214.69
Retained Earnings	-341.74	-289.23	-250.27	-197.23	-149.31	-103.13
Comprehensive Income & Other	-	-	-	-	-0.56	-0.18
Total Common Equity	66.3	42.52	28.82	76.51	68.49	111.37
Shareholders' Equity	66.3	42.52	28.82	76.51	68.49	111.37
Total Liabilities & Equity	91.95	53.02	45.21	103.95	85.65	126.49

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	8.32	0.74	2.77	4.61	6.32	6.53
Net Cash (Debt)	79.37	48.17	35.99	91.73	72.76	82.44
Net Cash Growth	751.51%	33.85%	-60.77%	26.07%	-11.74%	-45.32%
Net Cash Per Share	39.98	62.84	65.42	178.65	231.95	264.66
Filing Date Shares Outstanding	2.87	1.37	0.56	0.55	0.53	0.31
Total Common Shares Outstanding	2.87	1.37	0.56	0.55	0.31	0.31
Working Capital	71.59	42.03	28.96	77.72	71.16	83.02
Book Value Per Share	23.07	30.99	51.18	139.85	217.64	355.56
Tangible Book Value	66.3	42.52	28.82	76.51	68.49	111.37
Tangible Book Value Per Share	23.07	30.99	51.18	139.85	217.64	355.56